Dose-dense administration of combinative paclitaxel and cisplatin might suppress the repopulation of ovarian cancer cell SKOV3

He Huan; Li Xuemei; Cheng Min; Linghu Hua

您当前的位置：

首页 >

文章列表页 >

Dose-dense administration of combinative paclitaxel and cisplatin might suppress the repopulation of ovarian cancer cell SKOV3

更新时间：2023-12-18

- Dose-dense administration of combinative paclitaxel and cisplatin might suppress the repopulation of ovarian cancer cell SKOV3
- Journal of Chongqing Medical University Vol. 38, Issue 11, Pages: 1526-1532(2014)
- 作者机构：
  
  重庆医科大学附属第一医院妇产科
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2014，
扫描看全文
He Huan, Li Xuemei, Cheng Min, et al. Dose-dense administration of combinative paclitaxel and cisplatin might suppress the repopulation of ovarian cancer cell SKOV3. [J]. Journal of Chongqing Medical University 38(11):1526-1532(2014)
DOI：

He Huan, Li Xuemei, Cheng Min, et al. Dose-dense administration of combinative paclitaxel and cisplatin might suppress the repopulation of ovarian cancer cell SKOV3. [J]. Journal of Chongqing Medical University 38(11):1526-1532(2014) DOI：

摘要

目的：比较顺铂（cisplatin，CDDP）与紫杉醇（paclitaxel，PTX）不同的给药方案对卵巢癌细胞种群恢复的影响。方法：（1）CDDP、PTX或CDDP联合PTX分别于第1天（D1）或D1及D8处理卵巢癌SKOV3细胞；（2）倒置显微镜观察不同处理组中，SKOV3细胞凋亡与种群恢复的情况；（3）CCK-8法分别测定不同处理组在D7和D21时SKOV3细胞的吸光度（absorbance，A）值。结果：（1）单用CDDP组中，单次给药组与分次给药组相比较，二者对SKOV3细胞的凋亡与种群恢复的影响无明显差异（P=0.970）；（2）单用PTX组中，与单次给药组相比，分次给药组明显抑制了SKOV3细胞的种群恢复（P=0.000）；（3）CDDP联合PTX组中，分次给药组较单次给药组对SKOV3细胞的种群恢复明显抑制（P=0.000），并且在分次给药组中，CDDP联合PTX组较单用PTX组明显抑制SKOV3细胞的种群恢复（P=0.000）。结论：CDDP联合PTX分次给药较单次给药可能通过抑制卵巢癌细胞的种群恢复从而抑制卵巢癌的耐药或复发。

Abstract

Objective：To compare the impact of different dosage regimens of cisplatin（CDDP） or/and paclitaxel（PTX） on the repopu－lation of ovarian cancer cells. Methods：（1）SKOV3 cells were treated with CDDP，PTX or CDDP combined with PTX respective－ly，each arm treated with fractional dose regimen（the total dosage was dividedly administration on d1 and d8） or single dose regimen（the total dosage was administration on d1）；（2）The apoptosis and repopulation of SKOV3 cells were observed under microscope；（3）The cell survival on d7 and d21 in each group was detected by CCK-8 method. Results：（1）In CDDP groups，no significant dif－ference was found between the two regimens（P=0.970）；（2）In PTX groups，the repopulation of SKOV3 cells in fractional dose regi－men was significantly inhibited compared with that of single dose regimen（P=0.000）；（3）Fractional schedule significantly inhibited the repopulation of SKOV3 cells in CDDP+PTX groups（P=0.000），and such suppressive efficiency was even more evident in CDDP+PTX group than in PTX monotherapy group（P=0.000）. Conclusion：CDDP+PTX with fractional dose regimen might prevent resistance or recurrence of ovarian cancer cells through significantly inhibiting the repopulation of ovarian cancer cells.

关键词

顺铂紫杉醇单次给药分次给药SKOV3

Keywords

cisplatinpaclitaxelsingle dose regimenfractional dose regimenSKOV3

references

Views

396

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Paclitaxel/oxaliplatin versus paclitaxel/cisplatin for advanced non-small cell lung cancer：a Meta analysis of randomized controlled trial

Effect of Glycyrrhiza uralensis Fisch. endophytes combined with cisplatin on proliferation and apoptosis of A549 cells

Study on the sensitizing effect of SCR7 on cisplatin chemotherapy in triple-negative breast cancer

Inhibitory effect of dihydroartemisinin combined with cisplatin on the proliferation of bladder cancer cells

The median-effect principle was used in the interaction between DDP,VP-16 on human lung cancer cell line(PAa)

Related Author

Wang Jingya

Long Rui

Wang Hongmei

Chen Hong

Qiu Feng

Zhang Shanglong

Zhang Nan

Lian Xiaolong

Related Institution

Department of Pharmacy

Department of Respiratory，The First Affiliated Hospital of Chongqing Medical University

College of Pharmacy，Gansu University of Chinese Medicine

Department of Internal Oncology，People's Hospital of Inner Mongolia Medical University

Teaching and Research Section of Immunology，School of Basic Medical Sciences，Inner Mongolia Medical University

⁰